Exact Sciences Serves Investors Exactly What They Wished For
Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ:EXAS) saw its shares spike over 17% on its Q1 2023 earnings results.
Source: valuewalk.com
Stay updated with breaking news from Prices Revert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ:EXAS) saw its shares spike over 17% on its Q1 2023 earnings results.
In terms of per-share profitability, Tysons, Virginia-based Park Hotels delivered earnings per share of 15 cents. This tally compares very favorably to a loss of 24 cents per share one year ago.
It’s not just Robert Shiller who says that stock prices revert to the mean. John Bogle said that in his book Common Sense on Mutual Funds.